SNNAQ

Sienna Biopharmaceuticals, Inc. SNNAQ

SNNAQ
Sienna Biopharmaceuticals, Inc. CMRA
Comera Life Sciences Holdings, Inc. SYVC
Synovics Pharmaceuticals, Inc. RBSH
Rebus Holdings, Inc. GBIM
GlobeImmune, Inc. FPMI
FluoroPharma Medical, Inc. NTII
Neurobiological Technologies, Inc. KLDO
Kaleido Biosciences, Inc. ANTH
Anthera Pharmaceuticals, Inc. COTQF
Cotinga Pharmaceuticals Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SNNAQ CMRA SYVC RBSH GBIM FPMI NTII KLDO ANTH COTQF
6M 0.00 % -50.00 % 0.00 % 0.00 % -80.00 % 100.00 % 0.00 % 0.00 % 0.00 % 0.00 %
YTD 0.00 % -50.00 % 0.00 % -50.00 % -50.00 % 100.00 % 0.00 % 0.00 % -50.00 % 0.00 %
1Y 0.00 % -50.00 % 0.00 % 0.00 % -50.00 % 100.00 % 0.00 % 0.00 % -50.00 % 0.00 %
3Y 0.00 % -99.99 % 0.00 % -98.73 % -85.71 % -86.67 % 0.00 % -90.91 % 0.00 % 900.00 %
5Y -98.61 % -100.00 % 0.00 % -99.98 % -99.97 % -94.44 % -93.33 % -100.00 % -99.54 % -95.35 %
10Y -100.00 % -100.00 % 0.00 % -100.00 % -100.00 % -99.93 % -99.53 % -100.00 % -100.00 % -99.96 %
From the beginning -100.00 % -100.00 % 0.00 % -100.00 % -100.00 % -99.98 % -100.00 % -100.00 % -100.00 % -99.98 %

Dividend

Neurobiological Technologies, Inc.